BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4521198)

  • 1. The effect of aspirin on sickling and oxygen affinity of erythrocytes.
    De Furia FG; Cerami A; Bunn HF; Lu YS; Peterson CM
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3707-10. PubMed ID: 4521198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl adipimidate: a new antisickling agent.
    Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickling as a function of oxygen delivery: effect of simulated transfusions of stored, fresh and inositol-hexaphosphate-loaded (low affinity) red cells.
    Kumpati J; Franco RS; Weiner M; Martelo OJ
    Blood Cells; 1982; 8(2):263-72. PubMed ID: 7159750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light scattering studies of retardation of sickling by aspirin-like drugs.
    Rabinowitz IN; Wolf PL; Berman S
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):417-20. PubMed ID: 4852998
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation.
    Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG
    J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of sickle hemoglobin by acetaldehyde and its effect on oxygenation, gelation and sickling.
    Abraham EC; Stallings M; Abraham A; Garbutt GJ
    Biochim Biophys Acta; 1982 Jul; 705(1):76-81. PubMed ID: 7115734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of zinc on increasing oxygen affinity of sickle and normal red blood cells.
    Oelshlegel FJ; Brewer GJ; Prasad AS; Knutsen C; Schoomaker EB
    Biochem Biophys Res Commun; 1973 Jul; 53(2):560-6. PubMed ID: 4716987
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of erythrocyte sickling in vitro by DL-glyceraldehyde.
    Nigen AM; Manning JM
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):367-71. PubMed ID: 264689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increased Bohr effect in sickle cell anemia.
    Ueda Y; Nagel RL; Bookchin RM
    Blood; 1979 Mar; 53(3):472-80. PubMed ID: 32940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes.
    Beddell CR; Goodford PJ; Kneen G; White RD; Wilkinson S; Wootton R
    Br J Pharmacol; 1984 Jun; 82(2):397-407. PubMed ID: 6733364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate.
    Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR
    Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of red cell sickling. Effects of varying pH and of increasing intracellular hemoglobin concentration by osmotic shrinkage.
    Bookchin RM; Balazs T; Landau LC
    J Lab Clin Med; 1976 Apr; 87(4):597-616. PubMed ID: 5563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen transport in sickle cell anemia.
    Milner PF
    Arch Intern Med; 1974 Apr; 133(4):565-72. PubMed ID: 4594394
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative aspirins as antisickling agents: acetyl-3,5-dibromosalicylic acid.
    Walder JA; Zaugg RH; Iwaoka RS; Watkin WG; Klotz IM
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5499-503. PubMed ID: 271972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z; Louderback JG; King SB; Ballas SK; Kim-Shapiro DB
    Am J Hematol; 2001 Jul; 67(3):151-6. PubMed ID: 11391710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.